ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML
Prescription Only
Drug type: Therapeutic
ATC code: L04AA43
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route of administration: INTRAVENOUS
Active ingredient: Ravulizumab; Ravulizumab
Registrant
ASTRAZENECA SINGAPORE PTE LTD
Approval Date
2024-06-19
Approval Number
SIN17026P
Manufacturer
Catalent Indiana, LLC
Alexion Pharma International Operations Limited (AAMF)
